- Home
- HRMY vs CMRE Comparison
HRMY vs CMRE Comparison
Compare HRMY & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- CMRE
- Stock Information
- Founded
- HRMY 2017
- CMRE 1974
- Country
- HRMY United States
- CMRE Monaco
- Employees
- HRMY N/A
- CMRE N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- CMRE Marine Transportation
- Sector
- HRMY Health Care
- CMRE Consumer Discretionary
- Exchange
- HRMY Nasdaq
- CMRE Nasdaq
- Market Cap
- HRMY 2.0B
- CMRE 1.9B
- IPO Year
- HRMY 2020
- CMRE 2010
- Fundamental
- Price
- HRMY $39.05
- CMRE $12.29
- Analyst Decision
- HRMY Strong Buy
- CMRE Hold
- Analyst Count
- HRMY 8
- CMRE 2
- Target Price
- HRMY $55.00
- CMRE $13.50
- AVG Volume (30 Days)
- HRMY 593.9K
- CMRE 278.0K
- Earning Date
- HRMY 02-20-2025
- CMRE 02-05-2025
- Dividend Yield
- HRMY N/A
- CMRE 3.74%
- EPS Growth
- HRMY N/A
- CMRE N/A
- EPS
- HRMY 2.11
- CMRE 3.01
- Revenue
- HRMY $681,879,000.00
- CMRE $2,030,338,000.00
- Revenue This Year
- HRMY $24.79
- CMRE $19.29
- Revenue Next Year
- HRMY $19.00
- CMRE N/A
- P/E Ratio
- HRMY $18.55
- CMRE $4.09
- Revenue Growth
- HRMY 25.83
- CMRE 58.37
- 52 Week Low
- HRMY $28.14
- CMRE $10.14
- 52 Week High
- HRMY $41.61
- CMRE $17.58
- Technical
- Relative Strength Index (RSI)
- HRMY 71.30
- CMRE 39.30
- Support Level
- HRMY $35.72
- CMRE $12.32
- Resistance Level
- HRMY $37.16
- CMRE $12.92
- Average True Range (ATR)
- HRMY 1.29
- CMRE 0.36
- MACD
- HRMY 0.48
- CMRE -0.01
- Stochastic Oscillator
- HRMY 92.25
- CMRE 1.63
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.